Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study

OBJECTIVE: Evidence on the prognostic value of autologous stem cell transplantation (ASCT) and minimal residual disease (MRD) dynamics of patients with newly diagnosed multiple myeloma (NDMM) in China is limited. Our objective in the current study was to understand the current care paradigm and outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Huishou, Wang, Weida, Zhang, Ya, Wang, Jianxiang, Cheng, Tao, Qiu, Lugui, Wang, Xin, Xia, Zhongjun, An, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843447/
https://www.ncbi.nlm.nih.gov/pubmed/36647781
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843447/
https://www.ncbi.nlm.nih.gov/pubmed/36647781
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0612

Ejemplares similares